fashion -WSS

fashion

author：entertainment 2025-08-08 05:32:58 - browse：1

Sammy Kimball for STAT

Can biotech startups survive a downturn? Is Covid-19 a good business? And when did ophthalmology get so dramatic?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we discuss what some recent layoffs and a reverse merger mean for biotech in 2023. We’ll also discuss the latest news in the life sciences, including a dramatic saga in ocular medicine, the volatile business of Covid-19, and some major milestones in gene therapy.

For more on what we cover, here’s the news on Celsius Therapeutics; here’s more on EQRx; here’s the latest on Apellis Pharmaceuticals; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Measles policy set amid Florida outbreak alarms vaccine proponents

WSS

AstraZeneca challenges Medicare drug negotiation program

Medicare explains how it will choose drugs for negotiation

Medicare Advantage enrollment grows 7.1% to 33.4 million people

In science, is the line between industry and academia shifting?

Secretariat’s lessons for human medicine

Feds fine Medicare Advantage plans for overcharging members

focus

fashion

knowledge

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Feds fine Medicare Advantage plans for overcharging members

In Memoriam: Notable people who died in 2023

WATCH: Why do our ears pop?

The high cost of giving birth even with insurance

WATCH: Why do our ears pop?

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Psilocybin's anti

knowledge

AstraZeneca bets AAV gene therapy will still deliver the goods

FDA panel gives mixed vote on blood pressure devices

How to make Best Hospitals ratings actually useful for patients

Diversity in medical illustrations gets boost from Chidiebere Ibe

Weight loss drugs aren’t covered by Obamacare. That may change

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

explore

entertainment

entertainment

hotspot